Login to Your Account

Livid over Lipids No Longer; Alnylam, Tekmira Find Peace

By Randy Osborne
Staff Writer

Wednesday, November 14, 2012
Alnylam Pharmaceuticals Inc.'s eleventh-hour settlement with Tekmira Pharmaceuticals Corp. leaves Alnylam $65 million lighter but still in strong financial shape, without losing rights to access the Lipid NanoParticle (LNP) delivery technology important for its RNAi work.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription